Thrombocytopenia Caused by Dexamethasone in a Patient with Colorectal Cancer.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
2020
Historique:
entrez: 15 10 2020
pubmed: 16 10 2020
medline: 20 2 2021
Statut: ppublish

Résumé

Drug-induced immune thrombocytopenia (DITP) is an important cause of thrombocytopenia. A 73-year-old man with relapsed rectal carcinoma received S-1, oxaliplatin and bevacizumab combination therapy (SOX+Bev). Dexamethasone was administered as an antiemetic prophylaxis. On day 2 of the first cycle, thrombocytopenia (8,000/μL) was observed. We sequentially omitted any drugs suspected to possibly induce thrombocytopenia and confirmed dexamethasone as the cause of thrombocytopenia. DITP induced by synthetic corticosteroids is very rare and this is the first case report of DITP induced by dexamethasone. Although rare, DITP due to synthetic corticosteroids including dexamethasone should be a differential diagnosis among patients receiving synthetic corticosteroids with thrombocytopenia.

Identifiants

pubmed: 33055471
doi: 10.2169/internalmedicine.4785-20
pmc: PMC7662045
doi:

Substances chimiques

Antiemetics 0
Dexamethasone 7S5I7G3JQL

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2571-2575

Références

Blood. 1991 Jun 15;77(12):2668-76
pubmed: 1710517
J Gerontol A Biol Sci Med Sci. 2002 Aug;57(8):M519-20
pubmed: 12145365
J Pharm Pract. 2014 Oct;27(5):430-9
pubmed: 25134884
Ann Intern Med. 1998 Dec 1;129(11):886-90
pubmed: 9867731
N Engl J Med. 2007 Aug 9;357(6):580-7
pubmed: 17687133
Blood. 2003 Sep 1;102(5):1670-7
pubmed: 12738668
Hematology Am Soc Hematol Educ Program. 2009;:153-8
pubmed: 20008194
J Thromb Haemost. 2013 Jan;11(1):169-76
pubmed: 23121994
Ann Med Interne (Paris). 1994;145(5):357-60
pubmed: 7985949
Blood. 2010 Jul 1;115(26):5431-2
pubmed: 20595525
Drug Saf. 2004;27(15):1243-52
pubmed: 15588119
Blood. 2018 Mar 29;131(13):1486-1489
pubmed: 29439950
DICP. 1990 Jul-Aug;24(7-8):693-5
pubmed: 1695793
Transfus Med Rev. 2013 Jul;27(3):137-45
pubmed: 23845922

Auteurs

Ryosuke Taguchi (R)

Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Japan.

Kenji Tsuchihashi (K)

Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Japan.

Yuta Okumura (Y)

Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Japan.

Michitaka Nakano (M)

Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Japan.

Tomoyasu Yoshihiro (T)

Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Japan.

Hirofumi Ohmura (H)

Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Japan.

Nobuhiro Tsuruta (N)

Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Japan.

Fumiyasu Hanamura (F)

Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Japan.

Kyoko Yamaguchi (K)

Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Japan.

Mamoru Ito (M)

Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Japan.

Hiroshi Ariyama (H)

Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Japan.

Hitoshi Kusaba (H)

Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Japan.

Koichi Akashi (K)

Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Japan.

Eishi Baba (E)

Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH